HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Nohara Selected Research

Myocardial Infarction

5/2023Coronary artery calcium among patients with heterozygous familial hypercholesterolaemia.
2/2023Impact of Healthy Lifestyle in Patients With Familial Hypercholesterolemia.
1/2023Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia.
1/2022Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia.
12/2021Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Nohara Research Topics

Disease

48Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
06/2024 - 05/2002
22Coronary Artery Disease (Coronary Atherosclerosis)
02/2024 - 05/2002
18Cardiovascular Diseases (Cardiovascular Disease)
05/2023 - 03/2015
13Xanthomatosis (Xanthoma)
02/2024 - 06/2005
13Atherosclerosis
11/2023 - 12/2002
8Homozygous Familial Hypercholesterolemia
12/2023 - 02/2012
7Hypercholesterolemia
08/2016 - 12/2011
6Coronary Disease (Coronary Heart Disease)
01/2019 - 12/2002
6Hypertriglyceridemia
01/2018 - 05/2005
6Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2015 - 10/2004
5Sitosterolemia
01/2024 - 08/2018
5Dyslipidemias (Dyslipidemia)
01/2024 - 04/2007
5Unstable Angina
05/2023 - 07/2018
5Myocardial Infarction
05/2023 - 12/2021
5Hypertension (High Blood Pressure)
10/2020 - 01/2016
5Type 2 Diabetes Mellitus (MODY)
03/2018 - 04/2006
5Insulin Resistance
01/2013 - 03/2007
4Chronic Renal Insufficiency
10/2023 - 01/2016
4Stroke (Strokes)
12/2021 - 03/2017
4Acute Coronary Syndrome
12/2021 - 01/2017
4Inborn Genetic Diseases (Disease, Hereditary)
01/2019 - 01/2012
4Hyperlipidemias (Hyperlipidemia)
08/2018 - 10/2004
3Hypobetalipoproteinemias (Hypobetalipoproteinemia)
01/2020 - 01/2009
3Fatty Liver
01/2020 - 01/2009
3Glucose Intolerance
03/2018 - 07/2011
3Pancreatitis
01/2016 - 12/2005
3Cholesteryl Ester Transfer Protein Deficiency
11/2014 - 02/2008
3Inflammation (Inflammations)
08/2009 - 12/2004
2Neoplasms (Cancer)
10/2020 - 11/2016
2Diabetes Mellitus
06/2019 - 01/2015
2Body Weight (Weight, Body)
01/2019 - 01/2015
2Heart Failure
01/2018 - 01/2017
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2016 - 07/2015
2Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2009 - 05/2006
2Aortic Valve Stenosis (Aortic Stenosis)
05/2009 - 12/2006
1Rupture
07/2023
1Blood Vessel Dissection
07/2023
1Type IV Ehlers-Danlos Syndrome
07/2023
1Vascular Diseases (Vascular Disease)
07/2023
1Aneurysm (Aneurysms)
07/2023
1Collagen Diseases (Collagen Disease)
12/2021

Drug/Important Bio-Agent (IBA)

37oxidized low density lipoproteinIBA
06/2024 - 12/2002
32LDL CholesterolIBA
12/2023 - 12/2002
29LipidsIBA
01/2024 - 01/2004
22LDL Lipoproteins (beta Lipoproteins)IBA
06/2024 - 12/2002
14LDL Receptors (LDL Receptor)IBA
11/2022 - 12/2002
14Lipoproteins (Lipoprotein)IBA
04/2019 - 10/2004
14Triglycerides (Triacylglycerol)IBA
01/2019 - 12/2002
13CholesterolIBA
03/2021 - 12/2002
10Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2023 - 07/2002
8omega-Chloroacetophenone (Mace)IBA
02/2023 - 03/2015
8Glucose (Dextrose)FDA LinkGeneric
01/2012 - 12/2004
7HDL CholesterolIBA
01/2023 - 04/2007
7Proprotein Convertase 9IBA
11/2020 - 07/2011
6ApolipoproteinsIBA
01/2019 - 10/2004
5Apolipoproteins B (ApoB)IBA
01/2021 - 01/2009
5Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2007
4gamma-sitosterol (beta-sitosterol)IBA
01/2024 - 01/2015
4colestimideIBA
09/2018 - 05/2005
4Ezetimibe (Zetia)FDA Link
09/2018 - 02/2012
4Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2018 - 12/2005
4Cholesterol Ester Transfer ProteinsIBA
11/2014 - 12/2002
3Lipoprotein(a)IBA
12/2022 - 01/2016
3BMS201038IBA
04/2019 - 04/2017
3SterolsIBA
12/2018 - 01/2010
3alirocumabIBA
08/2016 - 12/2015
3Heparin (Liquaemin)FDA LinkGeneric
04/2016 - 03/2007
3Insulin (Novolin)FDA Link
01/2013 - 05/2005
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2009 - 12/2004
2Adenosine Triphosphate (ATP)IBA
01/2024 - 12/2018
2CalciumIBA
05/2023 - 07/2018
2HDL LipoproteinsIBA
01/2023 - 01/2002
2Phytosterols (Plant Sterols)IBA
09/2018 - 08/2018
2Fibric Acids (Fibrates)IBA
01/2017 - 01/2013
2Lipase (Acid Lipase)FDA Link
04/2016 - 11/2006
2Asparaginase (Elspar)FDA Link
01/2016 - 07/2015
2SteroidsIBA
01/2016 - 07/2015
2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2015 - 06/2005
2IsotopesIBA
01/2015 - 02/2012
2VLDL LipoproteinsIBA
02/2012 - 01/2009
2Rosuvastatin Calcium (Crestor)FDA Link
02/2012 - 01/2004
2BezafibrateIBA
07/2011 - 05/2011
2Fenofibrate (CiL)FDA LinkGeneric
07/2011 - 04/2006
2AdipokinesIBA
07/2011 - 01/2011
2Atorvastatin (Lipitor)FDA Link
05/2011 - 05/2005
2Apolipoprotein E2IBA
05/2011 - 10/2004
2Biomarkers (Surrogate Marker)IBA
01/2011 - 03/2007
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2009 - 12/2004
2Apolipoproteins E (ApoE)IBA
02/2008 - 10/2004
1Adenosine (Adenocard)FDA LinkGeneric
01/2024
1CollagenIBA
07/2023
1C-Reactive ProteinIBA
12/2022

Therapy/Procedure

18Therapeutics
12/2023 - 01/2005
6Blood Component Removal (Apheresis)
12/2021 - 05/2009
3Drug Therapy (Chemotherapy)
04/2017 - 05/2009
2Percutaneous Coronary Intervention
11/2020 - 07/2018
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2020 - 07/2018
2Secondary Prevention
06/2019 - 05/2009
2Fat-Restricted Diet (Diet, Fat Restricted)
04/2019 - 01/2019
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
07/2015 - 06/2005